A team of university scientists has cleared a major scientific hurdle that should lay the foundation for the development of new drugs to combat tuberculosis, a disease that killed 1.8 million people in 2007.
The team uncovered the structure and function of NAD+ synthetase, an enzyme essential for the survival of tuberculosis-causing bacteria, that could help scientists develop drugs to fight the deadly disease.
